HIV Risk Reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study

HIV risk was evaluated among 487 cocaine-dependent patients recruited from five treatment programs in a trial that examined the efficacy of four outpatientbased psychosocial treatments. Treatments were offered two to three times per week for 6 months and consisted of group drug counseling (GDC) or g...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of acquired immune deficiency syndromes (1999) 2003-05, Vol.33 (1), p.82-87
Hauptverfasser: Woody, George E, Gallop, Robert, Luborsky, Lester, Blaine, Jack, Frank, Arlene, Salloum, Ihsan M, Gastfriend, David, Crits-Christoph, Paul
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 87
container_issue 1
container_start_page 82
container_title Journal of acquired immune deficiency syndromes (1999)
container_volume 33
creator Woody, George E
Gallop, Robert
Luborsky, Lester
Blaine, Jack
Frank, Arlene
Salloum, Ihsan M
Gastfriend, David
Crits-Christoph, Paul
description HIV risk was evaluated among 487 cocaine-dependent patients recruited from five treatment programs in a trial that examined the efficacy of four outpatientbased psychosocial treatments. Treatments were offered two to three times per week for 6 months and consisted of group drug counseling (GDC) or group counseling plus individual drug counseling (IDC), cognitive therapy (CT), or supportive-expressive therapy (SE). The average patient had used cocaine for 7 years, with 10 days of use in the last month. Crack smoking was the main route in 79%, and HIV risk was mainly due to multiple partners and unprotected sex. Treatment was associated with a decrease in cocaine use from an average of 10 days per month at baseline to 1 day per month at 6 months. Reduction in cocaine use was associated with an average 40% decrease in HIV risk across all treatment, gender, and ethnic groups, mainly as a result of fewer sexual partners and less unprotected sex. The combination of IDC and GDC was associated with an equal or even greater reduction in HIV risk than the other treatment conditions and thus shows promise as an effective HIV prevention strategy, at least for some patients.
doi_str_mv 10.1097/00126334-200305010-00012
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18824018</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18824018</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4372-f24f5656ce93a478954dfd0552998319003217eb323ac7ee532bf2a0f2c24aa93</originalsourceid><addsrcrecordid>eNp1kclOwzAQQC0EoqXwC8gnbgGvTXxEZWmlCiQoXI2TTGggTYoXqv49Li1w4jQe-83YfoMQpuScEpVeEELZkHORMEI4kYSShGz29lCfKiGSNMvEflxLJhNBueyhI-feIjEUQh2iHmWpYlyqPnoZT57xQ-3e8QOUofB11-K6xX4O-M5sMtPgSet87YMHHA-vbHjFl3lwgEddYep2E5vG5J2N_CfgmQXjF9B6_OhDuT5GB5VpHJzs4gA93VzPRuNken87GV1Ok0LwlCUVE5UcymEBihuRZkqKsiqJlEypjFMV_8loCjln3BQpgOQsr5ghFSuYMEbxATrb9l3a7iOA83pRuwLiy1rogtM0y5ggNItgtgUL2zlnodJLWy-MXWtK9Mau_rGrf-3qb7ux9HR3R8gXUP4V7nRGQGyBVdd4sO69CSuweg6m8XP939T4F6qYg6Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18824018</pqid></control><display><type>article</type><title>HIV Risk Reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study</title><source>Ovid Lippincott Williams and Wilkins Journal Legacy Archive</source><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Free E- Journals</source><creator>Woody, George E ; Gallop, Robert ; Luborsky, Lester ; Blaine, Jack ; Frank, Arlene ; Salloum, Ihsan M ; Gastfriend, David ; Crits-Christoph, Paul</creator><creatorcontrib>Woody, George E ; Gallop, Robert ; Luborsky, Lester ; Blaine, Jack ; Frank, Arlene ; Salloum, Ihsan M ; Gastfriend, David ; Crits-Christoph, Paul ; Cocaine Psychotherapy Study Group</creatorcontrib><description>HIV risk was evaluated among 487 cocaine-dependent patients recruited from five treatment programs in a trial that examined the efficacy of four outpatientbased psychosocial treatments. Treatments were offered two to three times per week for 6 months and consisted of group drug counseling (GDC) or group counseling plus individual drug counseling (IDC), cognitive therapy (CT), or supportive-expressive therapy (SE). The average patient had used cocaine for 7 years, with 10 days of use in the last month. Crack smoking was the main route in 79%, and HIV risk was mainly due to multiple partners and unprotected sex. Treatment was associated with a decrease in cocaine use from an average of 10 days per month at baseline to 1 day per month at 6 months. Reduction in cocaine use was associated with an average 40% decrease in HIV risk across all treatment, gender, and ethnic groups, mainly as a result of fewer sexual partners and less unprotected sex. The combination of IDC and GDC was associated with an equal or even greater reduction in HIV risk than the other treatment conditions and thus shows promise as an effective HIV prevention strategy, at least for some patients.</description><identifier>ISSN: 1525-4135</identifier><identifier>EISSN: 1944-7884</identifier><identifier>DOI: 10.1097/00126334-200305010-00012</identifier><identifier>PMID: 12792359</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins, Inc</publisher><subject>Adolescent ; Adult ; Antisocial Personality Disorder ; Cocaine-Related Disorders - complications ; Cocaine-Related Disorders - therapy ; Continental Population Groups ; Female ; HIV Infections - complications ; HIV Infections - etiology ; HIV Infections - prevention &amp; control ; HIV Infections - transmission ; Humans ; Male ; Middle Aged ; National Institutes of Health (U.S.) ; Patient Dropouts ; Psychotherapy ; Risk Factors ; Risk Reduction Behavior ; Safe Sex ; Sex Factors ; Sexual Behavior ; Treatment Refusal ; United States</subject><ispartof>Journal of acquired immune deficiency syndromes (1999), 2003-05, Vol.33 (1), p.82-87</ispartof><rights>2003 Lippincott Williams &amp; Wilkins, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4372-f24f5656ce93a478954dfd0552998319003217eb323ac7ee532bf2a0f2c24aa93</citedby><cites>FETCH-LOGICAL-c4372-f24f5656ce93a478954dfd0552998319003217eb323ac7ee532bf2a0f2c24aa93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf><![CDATA[$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&PDF=y&D=ovft&AN=00126334-200305010-00012$$EPDF$$P50$$Gwolterskluwer$$H]]></linktopdf><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;NEWS=n&amp;CSC=Y&amp;PAGE=fulltext&amp;D=ovft&amp;AN=00126334-200305010-00012$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>314,780,784,4609,27924,27925,64666,65461</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12792359$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Woody, George E</creatorcontrib><creatorcontrib>Gallop, Robert</creatorcontrib><creatorcontrib>Luborsky, Lester</creatorcontrib><creatorcontrib>Blaine, Jack</creatorcontrib><creatorcontrib>Frank, Arlene</creatorcontrib><creatorcontrib>Salloum, Ihsan M</creatorcontrib><creatorcontrib>Gastfriend, David</creatorcontrib><creatorcontrib>Crits-Christoph, Paul</creatorcontrib><creatorcontrib>Cocaine Psychotherapy Study Group</creatorcontrib><title>HIV Risk Reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study</title><title>Journal of acquired immune deficiency syndromes (1999)</title><addtitle>J Acquir Immune Defic Syndr</addtitle><description>HIV risk was evaluated among 487 cocaine-dependent patients recruited from five treatment programs in a trial that examined the efficacy of four outpatientbased psychosocial treatments. Treatments were offered two to three times per week for 6 months and consisted of group drug counseling (GDC) or group counseling plus individual drug counseling (IDC), cognitive therapy (CT), or supportive-expressive therapy (SE). The average patient had used cocaine for 7 years, with 10 days of use in the last month. Crack smoking was the main route in 79%, and HIV risk was mainly due to multiple partners and unprotected sex. Treatment was associated with a decrease in cocaine use from an average of 10 days per month at baseline to 1 day per month at 6 months. Reduction in cocaine use was associated with an average 40% decrease in HIV risk across all treatment, gender, and ethnic groups, mainly as a result of fewer sexual partners and less unprotected sex. The combination of IDC and GDC was associated with an equal or even greater reduction in HIV risk than the other treatment conditions and thus shows promise as an effective HIV prevention strategy, at least for some patients.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Antisocial Personality Disorder</subject><subject>Cocaine-Related Disorders - complications</subject><subject>Cocaine-Related Disorders - therapy</subject><subject>Continental Population Groups</subject><subject>Female</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - etiology</subject><subject>HIV Infections - prevention &amp; control</subject><subject>HIV Infections - transmission</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>National Institutes of Health (U.S.)</subject><subject>Patient Dropouts</subject><subject>Psychotherapy</subject><subject>Risk Factors</subject><subject>Risk Reduction Behavior</subject><subject>Safe Sex</subject><subject>Sex Factors</subject><subject>Sexual Behavior</subject><subject>Treatment Refusal</subject><subject>United States</subject><issn>1525-4135</issn><issn>1944-7884</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kclOwzAQQC0EoqXwC8gnbgGvTXxEZWmlCiQoXI2TTGggTYoXqv49Li1w4jQe-83YfoMQpuScEpVeEELZkHORMEI4kYSShGz29lCfKiGSNMvEflxLJhNBueyhI-feIjEUQh2iHmWpYlyqPnoZT57xQ-3e8QOUofB11-K6xX4O-M5sMtPgSet87YMHHA-vbHjFl3lwgEddYep2E5vG5J2N_CfgmQXjF9B6_OhDuT5GB5VpHJzs4gA93VzPRuNken87GV1Ok0LwlCUVE5UcymEBihuRZkqKsiqJlEypjFMV_8loCjln3BQpgOQsr5ghFSuYMEbxATrb9l3a7iOA83pRuwLiy1rogtM0y5ggNItgtgUL2zlnodJLWy-MXWtK9Mau_rGrf-3qb7ux9HR3R8gXUP4V7nRGQGyBVdd4sO69CSuweg6m8XP939T4F6qYg6Q</recordid><startdate>20030501</startdate><enddate>20030501</enddate><creator>Woody, George E</creator><creator>Gallop, Robert</creator><creator>Luborsky, Lester</creator><creator>Blaine, Jack</creator><creator>Frank, Arlene</creator><creator>Salloum, Ihsan M</creator><creator>Gastfriend, David</creator><creator>Crits-Christoph, Paul</creator><general>Lippincott Williams &amp; Wilkins, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U1</scope><scope>7U2</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope></search><sort><creationdate>20030501</creationdate><title>HIV Risk Reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study</title><author>Woody, George E ; Gallop, Robert ; Luborsky, Lester ; Blaine, Jack ; Frank, Arlene ; Salloum, Ihsan M ; Gastfriend, David ; Crits-Christoph, Paul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4372-f24f5656ce93a478954dfd0552998319003217eb323ac7ee532bf2a0f2c24aa93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antisocial Personality Disorder</topic><topic>Cocaine-Related Disorders - complications</topic><topic>Cocaine-Related Disorders - therapy</topic><topic>Continental Population Groups</topic><topic>Female</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - etiology</topic><topic>HIV Infections - prevention &amp; control</topic><topic>HIV Infections - transmission</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>National Institutes of Health (U.S.)</topic><topic>Patient Dropouts</topic><topic>Psychotherapy</topic><topic>Risk Factors</topic><topic>Risk Reduction Behavior</topic><topic>Safe Sex</topic><topic>Sex Factors</topic><topic>Sexual Behavior</topic><topic>Treatment Refusal</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Woody, George E</creatorcontrib><creatorcontrib>Gallop, Robert</creatorcontrib><creatorcontrib>Luborsky, Lester</creatorcontrib><creatorcontrib>Blaine, Jack</creatorcontrib><creatorcontrib>Frank, Arlene</creatorcontrib><creatorcontrib>Salloum, Ihsan M</creatorcontrib><creatorcontrib>Gastfriend, David</creatorcontrib><creatorcontrib>Crits-Christoph, Paul</creatorcontrib><creatorcontrib>Cocaine Psychotherapy Study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of acquired immune deficiency syndromes (1999)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Woody, George E</au><au>Gallop, Robert</au><au>Luborsky, Lester</au><au>Blaine, Jack</au><au>Frank, Arlene</au><au>Salloum, Ihsan M</au><au>Gastfriend, David</au><au>Crits-Christoph, Paul</au><aucorp>Cocaine Psychotherapy Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HIV Risk Reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study</atitle><jtitle>Journal of acquired immune deficiency syndromes (1999)</jtitle><addtitle>J Acquir Immune Defic Syndr</addtitle><date>2003-05-01</date><risdate>2003</risdate><volume>33</volume><issue>1</issue><spage>82</spage><epage>87</epage><pages>82-87</pages><issn>1525-4135</issn><eissn>1944-7884</eissn><abstract>HIV risk was evaluated among 487 cocaine-dependent patients recruited from five treatment programs in a trial that examined the efficacy of four outpatientbased psychosocial treatments. Treatments were offered two to three times per week for 6 months and consisted of group drug counseling (GDC) or group counseling plus individual drug counseling (IDC), cognitive therapy (CT), or supportive-expressive therapy (SE). The average patient had used cocaine for 7 years, with 10 days of use in the last month. Crack smoking was the main route in 79%, and HIV risk was mainly due to multiple partners and unprotected sex. Treatment was associated with a decrease in cocaine use from an average of 10 days per month at baseline to 1 day per month at 6 months. Reduction in cocaine use was associated with an average 40% decrease in HIV risk across all treatment, gender, and ethnic groups, mainly as a result of fewer sexual partners and less unprotected sex. The combination of IDC and GDC was associated with an equal or even greater reduction in HIV risk than the other treatment conditions and thus shows promise as an effective HIV prevention strategy, at least for some patients.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins, Inc</pub><pmid>12792359</pmid><doi>10.1097/00126334-200305010-00012</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1525-4135
ispartof Journal of acquired immune deficiency syndromes (1999), 2003-05, Vol.33 (1), p.82-87
issn 1525-4135
1944-7884
language eng
recordid cdi_proquest_miscellaneous_18824018
source Ovid Lippincott Williams and Wilkins Journal Legacy Archive; MEDLINE; Journals@Ovid Complete; Free E- Journals
subjects Adolescent
Adult
Antisocial Personality Disorder
Cocaine-Related Disorders - complications
Cocaine-Related Disorders - therapy
Continental Population Groups
Female
HIV Infections - complications
HIV Infections - etiology
HIV Infections - prevention & control
HIV Infections - transmission
Humans
Male
Middle Aged
National Institutes of Health (U.S.)
Patient Dropouts
Psychotherapy
Risk Factors
Risk Reduction Behavior
Safe Sex
Sex Factors
Sexual Behavior
Treatment Refusal
United States
title HIV Risk Reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T16%3A32%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HIV%20Risk%20Reduction%20in%20the%20National%20Institute%20on%20Drug%20Abuse%20Cocaine%20Collaborative%20Treatment%20Study&rft.jtitle=Journal%20of%20acquired%20immune%20deficiency%20syndromes%20(1999)&rft.au=Woody,%20George%20E&rft.aucorp=Cocaine%20Psychotherapy%20Study%20Group&rft.date=2003-05-01&rft.volume=33&rft.issue=1&rft.spage=82&rft.epage=87&rft.pages=82-87&rft.issn=1525-4135&rft.eissn=1944-7884&rft_id=info:doi/10.1097/00126334-200305010-00012&rft_dat=%3Cproquest_cross%3E18824018%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18824018&rft_id=info:pmid/12792359&rfr_iscdi=true